Invokamet (canagliflozin/metformin hydrochloride)

pCPA File Number: 20955

Negotiation Status:

Concluded without agreement

Indication(s):

Diabetes Mellitus, Type 2

Sponsor/Manufacturer:

Janssen Inc.

CDA-AMC Project Number:

SR0480-000

pCPA Engagement Letter Issued:

2017-05-05

Negotiation Process Concluded:

2017-10-20